Suscribe to our monthly newsletter
|
|
Newsletter n°50 :
- 38 M€ to develop safer and more efficient medicines
- C4C : a project in favor of cell therapy
- In-Cell-Art will receive € 1.2 million to support the field of infectious diseases
- Dental Moving raises funds and widens its offer
- International Cooperation between Oniris and UC DAVIS
- TERM: on the right track to developing European research collaboration on Tissue Engineering and Regenerative Medicine
- Second phase of development for Atlantic Bio GMP
- Change of direction for Atlantic Bio GMP : Frédéric Dehaut hands on the torch to Sophie Derenne
- Keosys materializes 10 international partnerships
- Licensing : transforming innovation into a product
- AtlanStat celebrates its tenth birthday
- Biopractis : web site on line
- Launching of the 5th call for proposals : Innovative Medicines Initiative (IMI)
Read more
|
|
|
Newsletter n°49 :
- Biofortis : Mérieux NutriSciences spearhead
- BIOPRACTIS, a new training center for health biotechnologies in Nantes
- Zoom on the project PEDDOSE.NET
- Sarfus Mapping Lite turns a conventional optical microscope into a nanoscale measuring device
- Two industrial and financial partnerships signed CEERAM passes a course
- In-Cell-Art scientists published in the field of local siRNA delivery by non-viral vectors
- PhD FELLOWSHIP "Progreffe 2012" Transplantation and Immunology in Nantes, France
- EPEMED is moving to Luxembourg
- Vivalis: signature of a broad collaboration agreement and commercial license for the production of a monoclonal antibody
- Sanofi - Institut Pasteur 2012 Awards : € 480 000 for biomedical research
Read more
|
|
|
Newsletter n°48 :
- Investing for the Future: Healthcare LABEX, two more Loire valley projects awarded labels
- MIT Receives First ARRONAX Shipment, Launching Strontium-82 Validation Project
- New leaders named to head the Atlanpole Biotherapies cluster
- Atlanpole Biotherapies welcomed 13 new members and ramped up its international presence
- ALGENICS receives grant to support development of its technology for the production of monoclonal antibodies in oncology
- In-Cell-Art scientists published in the field of local siRNA delivery by non-viral vectors
- Effimune with its lead drug candidate FR104, selected through the consortium TRIAD (FP7)
- In2 Life Sciences, a new European program to benefit businesses
- PhD FELLOWSHIP "Progreffe 2012" Transplantation and Immunology in Nantes, France
- International CNRS-Higher Education chair in environmental genomic and systemic biology
- Maryvonne Hiance heads CJES, the Young Healthcare Sector Businesses club in LEEM
- Three new Biogenouest platforms recognised for their excellence with the IBiSA label
Read more
|
|
|
Newsletter n°47 :
- ArronaxPlus confirms the city of Nantes' leadership in the field of nuclear medicine
- Check out the Atlanpole Biotherapies online member directory!
- EPEMED: a non-profit founded in Nantes leads the debate on personalized medicine on the European level
- Vivalis and Sanofi Pasteur: a new human monoclonal antibody discovery target against a new infectious disease
- In-Cell-Art nanocarriers as powerful adjuvants for colorectal carcinoma immunotherapy by DNA vaccination
- The portrait of an innovative stakeholder from the Pays de la Loire region
- TMB: understanding pain in order to treat it more effectively
- Launch of the first ERA-NET TRANSCAN call for proposals on translational research in oncology
Read more
|
|
|
Newsletter n°45 :
- In-Cell-Art, Sanofi Pasteur and CureVac launch the RN-ARMORVAX consortium
- KEOSYS updates its IMAGYS web solution
- Partnering 360: the life science business network
- A new, innovation-focused event organized by the French Ministry of Higher Education and Research: “Contacts Innovation”
- A new call for proposals from the “Association pour la Recherche sur le Cancer” charity (ARC)
- First call for Franco-Japanese R&D proposals
- Call for proposals on technology collaborations between French and Canadian companies
- The “Outsourcing in Drug Development” conference, GSK campus, Evreux
Read more
|
|
|
Newsletter n°44 :
- A LEEM Biotech-Atlanpole Biotherapies meeting in Nantes
- An update on the TERM Project
- Atlantic Bone Screen reorganizes and recruits
- Vivalis and GeoVax Labs will collaborate to produce a component of GeoVax's HIV/AIDS vaccine
- Atlanpole Biotherapies’ international event program for 2012
- International Connecting Day 2011: a workshop full of valuable information !
- AFSSAPS: bulletin initiatives innovations issue 8
- A call for joint France/Canada proposals from OSEO
Read more
|
|
|
Newsletter n°43 :
- NANOFAR: a new European Doctorate in nanomedicine and pharmaceutical innovation
- Eurofins in Nantes becomes the largest single-site independent food testing laboratory in the world
- Porsolt inaugurates its new Research Centre
- Biomat-IN: a european project focused on
- European Cancer Cluster Partnering 2011 in Toulouse: key figures
- In-Cell-Art to participate in BioJapan World Business Forum
- The MarkeTech Group is recruiting for its Nantes office
- Lemer Pax wins a special prize at the 2011 Siemens Innovation Grand Prix
Read more
|
